Table 2.
Comparison of clinical characteristics between survived and nonsurvived ACLF patients.
| Non-survivals(n=38) | Survivals(n=38) | P value | |
|---|---|---|---|
| Age(years) | 50.24 ± 16.72 | 44.74 ± 13.25 | 0.116 |
| Male (%)∗ | 28 (73.68%) | 32 (84.21%) | 0.266 |
| TBIL(μmol/L) | 376.71 ± 184.18 | 247.26 ± 98.30 | <0.001 |
| Albumin(g/L) | 31.03 ± 4.56 | 30.26 ± 4.92 | 0.478 |
| ALT (U/L) | 202.50(85.00--856.25) | 263.00(107.5--327.25) | 0.901 |
| AST(U/L) | 201.00(128.25--571.75) | 252.00(115.00--445.25) | 0.954 |
| γ-GT (U/L) | 111.00(63.25--210.50) | 139.00(88.25--213.00) | 0.306 |
| WBC(×109/L) | 6.65(4.94--9.31) | 6.09 (4.15--8.10) | 0.187 |
| N% | 72.84 ± 8.96 | 66.77 ± 10.94 | 0.010 |
| Platelet(×109/L) | 88.00 (62.00--125.00) | 121.00 (67.50--145.00) | 0.245 |
| Plasma ammonia (μmol/l) |
64.85 ± 34.12 | 70.51 ± 27.81 | 0.444 |
| Blood lactic acid | 2.77 (2.20--3.50) | 2.39 (1.87--3.08) | 0.124 |
| PT(s) |
23.05(18.50--23.05) | 19.8(16.78--23.95) | 0.042 |
| INR | 2.00(1.60--2.44) | 1.73(1.45--2.10) | 0.041 |
| CRP(mg/L) | 19.15(10.06--27.64) | 17.15(7.28--25.42) | 0.421 |
| PCT(ng/mL) | 0.67 (0.38--1.24) | 0.86 (0.53--1.84) | 0.136 |
| Serum creatinine(umol/L) | 60.00(49.00--70.50) | 63.00(35.00--172.00) | 0.571 |
| MELD score | 21.37 ± 5.71 | 18.48 ± 5.11 | 0.022 |
| MELD-Na score | 19.38 ± 10.98 | 14.54 ± 8.92 | 0.039 |
∗Data in this table were obtained upon admission and expressed as the number of patients (percentage), mean ± standard deviation, or mean (interquartile range).